| CAT # | Igama lemveliso | Inkcazo |
| CPD100594 | TT15 | I-TT15 yi-agonist ye-GLP-1R. |
| CPD100593 | VU0453379 | I-VU0453379 yi-CNS-penetrant glucagon-like peptide 1 receptor (GLP-1R) positive allosteric module (PAM) |
| CPD100592 | PF-06882961 | I-PF-06882961 inamandla, i-agonist yomlomo ye-bioavailable ye-glucagon-like peptide-1 receptor (GLP-1R). |
| CPD100591 | PF-06372222 | PF-06372222 yi-molecule encinci ye-allosteric modulator (NAM) ye-glucagon receptor (GCGR). Abachasi be-GCGR banokuba luncedo ekuphatheni uhlobo lwe-2 yesifo sikashukela ngenxa yokuba balawula amanqanaba e-glucose ye-plasma ngokunciphisa okanye ukunciphisa ukuveliswa kwe-glucose ye-hepatic ngokubonakalisa isibindi, i-intestinal smooth muscle, intso, ingqondo kunye nezicubu ze-adipose. I-PF-06372222 ikwangumchasi we-glucagon-like peptide-1 receptor GLP-1R, enqanda ukukhutshwa kweglucagon kunye ne-glucose exhomekeke kwi-insulin secretion kwaye inokudlala indima ekukhululweni kwehomoni ekhokelela kuxinzelelo olubukhali kunye nolungapheliyo kunye noxinzelelo. Ngokumodareyitha kakubi i-GLP-1R, PF-06372222 inokunyanga uhlobo lwe-2 yesifo sikashukela kunye noxinzelelo kunye noxinzelelo. |
| CPD100590 | NNC0640 | I-NNC0640 yimodyuli ye-allosteric engalunganga ye-glucagon-like peptide-1 receptor (GLP-1R). |
| CPD100589 | HTL26119 | I-HTL26119 iyiveli ye-allosteric antagonist ye-glucagon-like peptide-1 receptor (GLP-1R). |
